The TAR‑200 slow‑release bladder implant cleared tumours in 82% of patients with high‑risk non‑muscle‑invasive bladder cancer, offering a promising new treatment approach.
Alberto Mantovani, Research Director at Istituto Superiore di Sanità reveals how the European Commission is taking action on endocrine disruptors (EDCs) and calls for a multidisciplinary network of cross-cutting silos
Cesare Onestini, Director of the European Training Foundation (ETF), has called for countries in and around the European Union to make education and training their number one priority if they want to compete in the global markets of the future
Minister for Disabled People, Health and Work Sarah Newton has urged large employers to build more inclusive workforces and report how many disabled staff they employ
The Oral Health Foundation is calling for free dental care for mouth cancer patients to combat the discriminatory costs of ongoing healthcare that survivors are often burdened with
Companies in Northumberland, Oxford and London will adopt new digital technologies, such as artificial intelligence, to support the manufacture of next-generation medicines and treatments
There are nearly 7,000 children and young adults under 25 currently being treated for type 2 diabetes in England and Wales - about 10 times the number reported before, according to Diabetes UK
Research released today reveals a gap between UK households’ passion for living sustainably versus a lack of understanding about managing their rubbish
Research commissioned by Zaizi, found over half of government departments are seeing slow or partial progress in digitising their processes, with even less exploring automation
Mike Taylor, Senior Accessibility Analyst and Comms and Training Manager at Digital Accessibility Centre shares his thoughts on maintaining accessibility through the EU Accessibility Directive
When it comes to the field of diabetic retinopathy research, Dr Lalit Pukhrambam at Wayne State University is exploring ways to prevent blinding eye diseases due to diabetes by targeting a protein called thioredoxin-interacting protein (TXNIP). Gene therapy is, therefore, a promising option
Prof Dr Regina Fluhrer from Biomedical Center (BMC), Ludwig Maximilians University of Munich (LMU) & German Center for Neurodegenerative Diseases (DZNE) shares her expertise on the field of intramembrane proteases, focussing on regulation of cellular pathways
People with health conditions will receive further support to manage their health conditions at work, thanks to 19 innovative projects set to receive millions in government funding
A new study, by AVADO, has revealed Britain's educational crisis as almost a third (32%) have a negative or indifferent attitude towards learning, including feeling lazy, unmotivated, nervous, tired or bored
